Deferasirox versus deferoxamine in managing iron overload in patients with Sickle Cell Anaemia: a systematic review and meta-analysis

OBJECTIVES: To examine the efficacy of deferasirox (DFX) by comparison with deferoxamine (DFO) in managing iron overload in patients with sickle cell anaemia (SCA). METHODS: Online databases were systematically searched for studies published from January 2007 to July 2022 that had investigated the e...

Descripción completa

Detalles Bibliográficos
Autor principal: Qadah, Talal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9793042/
https://www.ncbi.nlm.nih.gov/pubmed/36562113
http://dx.doi.org/10.1177/03000605221143290

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9793042/
https://www.ncbi.nlm.nih.gov/pubmed/36562113
http://dx.doi.org/10.1177/03000605221143290

Ejemplares similares